Endotoxin induced platelet microvesicle formation measured by flow cytometry

Platelets

Volumn 7, Issue 3, 1996, Pages 153-158

  Larsson, Anders ^a   Lundahl, Tom ^b   Eriksson, Mats ^a   Lundkvist, Kai ^a   Lindahl, Tomas ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BLOOD CLOTTING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEMOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SWINE; THROMBOCYTE ACTIVATION;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; SUIDAE; SUS SCROFA;

EID: 0029841238     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609023574     Document Type: Article

References (26)

1. Freudenberg MA, Galanos C. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. Inter Rev Immunol 1990; 6: 207-21.
2. Mammen EF. Perspective for the future. Intern Care Med 1993; 19: S29-34.
3. Modig J. Adult respiratory distress syndrome. Comp Path Bull 1989; 21: 2-4.
4. Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol Today 1992; 13: 271-76.
5. Talan DA. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers. Ann Emerg Med 1993; 22: 1871-90.
6. Grabarek J, Her GR, Reinhold VN, Hawiger J. Endotoxic lipid A interaction with human platelets. Structure-function analysis of lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide. J Biol Chem 1990; 265: 8117-21.
7. Larsson A, Egberg N, Lindahl TL. Platelet activation and binding of complement components to platelets induced by immune complexes. Platelets 1994; 5: 149-55.
8. Lindahl T, Larsson A. Clq binding to platelets induced by monoclonal antibodies and immune complexes - A flow cytometric analysis. Platelets 1993; 4: 73-7.
9. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombin activity. J Biol Chem 1988; 263: 18205-12.
10. Valone FH. Platelet-activating factor binding and metabolism during human platelet aggregation. Thromb Res 1988; 50: 103-12.
11. Owens MR. The role of platelet microparticles in hemostasis. Trans Med Rev 1994; 8: 27-44.
12. George PN, Pickett EB, Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68: 307-9.
13. George PN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Keiffer N, Newman PJ. Platelet surface glycoproteins: studies on resting and activated platelet and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-8.
14. McGill M, Fugman DA, Vittorio N, Darrow C. Platelet membrane microvesicles reduced microvascular bleeding times in thrombocytopenic rabbits. Lab Clin Med 1987; 109: 127-33.
15. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JI, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-drived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691-99.
16. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119: 334-45.
17. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994; 264: 365-7.
18. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 1993; 90: 9887-91.
19. Salden HIM, Bas BM. Endotoxin binding to platelets in blood from patients with a sepsis syndrome. Clin Chem 1994; 40: 1575-9.
20. Nyström ML, Barradas MA, Jeremy JY, Mikhailidis DP. Platelet shape change in whole blood: differential effects of endotoxin. Thromb Haemost 1994; 71: 646-50.
21. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-38.
22. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13: 269-88.
23. Howard MA, Coghlan M, David R, Pfueller SL. Coagulation activities of plasma microparticles. Thromb Res 1988; 50: 145-56.
24. Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro ageing. Blood 1991; 77: 887-95.
25. Lee YJ, Jy W. Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementia. Thromb Res 1993; 72: 295-304.
26. Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M. Demonstration of platelet derived microvesicles in blood from patients with activated coagulation and fibrinolysis using filtration techniques and Western blotting. Thromb Haemost 1994; 72: 666-71.